JP2019520393A5 - - Google Patents

Download PDF

Info

Publication number
JP2019520393A5
JP2019520393A5 JP2019500328A JP2019500328A JP2019520393A5 JP 2019520393 A5 JP2019520393 A5 JP 2019520393A5 JP 2019500328 A JP2019500328 A JP 2019500328A JP 2019500328 A JP2019500328 A JP 2019500328A JP 2019520393 A5 JP2019520393 A5 JP 2019520393A5
Authority
JP
Japan
Prior art keywords
composition according
pharmaceutical composition
pharmaceutically acceptable
emulsion
cellulose
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2019500328A
Other languages
English (en)
Japanese (ja)
Other versions
JP2019520393A (ja
Filing date
Publication date
Priority claimed from GBGB1611920.8A external-priority patent/GB201611920D0/en
Application filed filed Critical
Publication of JP2019520393A publication Critical patent/JP2019520393A/ja
Publication of JP2019520393A5 publication Critical patent/JP2019520393A5/ja
Withdrawn legal-status Critical Current

Links

JP2019500328A 2016-07-08 2017-07-06 医薬組成物 Withdrawn JP2019520393A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB1611920.8A GB201611920D0 (en) 2016-07-08 2016-07-08 Pharmaceutical compositions
GB1611920.8 2016-07-08
PCT/EP2017/066983 WO2018015175A1 (en) 2016-07-08 2017-07-06 Pharmaceutical compositions

Publications (2)

Publication Number Publication Date
JP2019520393A JP2019520393A (ja) 2019-07-18
JP2019520393A5 true JP2019520393A5 (cg-RX-API-DMAC7.html) 2020-08-06

Family

ID=56890842

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2019500328A Withdrawn JP2019520393A (ja) 2016-07-08 2017-07-06 医薬組成物

Country Status (20)

Country Link
US (1) US20200254046A1 (cg-RX-API-DMAC7.html)
EP (1) EP3481377A1 (cg-RX-API-DMAC7.html)
JP (1) JP2019520393A (cg-RX-API-DMAC7.html)
KR (1) KR20190026816A (cg-RX-API-DMAC7.html)
CN (1) CN109414409A (cg-RX-API-DMAC7.html)
AU (1) AU2017298873B2 (cg-RX-API-DMAC7.html)
BR (1) BR112019000240A2 (cg-RX-API-DMAC7.html)
CA (1) CA3029331A1 (cg-RX-API-DMAC7.html)
CL (1) CL2019000042A1 (cg-RX-API-DMAC7.html)
CO (1) CO2019000083A2 (cg-RX-API-DMAC7.html)
CR (1) CR20190007A (cg-RX-API-DMAC7.html)
DO (1) DOP2019000002A (cg-RX-API-DMAC7.html)
EA (1) EA201990162A1 (cg-RX-API-DMAC7.html)
GB (1) GB201611920D0 (cg-RX-API-DMAC7.html)
IL (1) IL263999A (cg-RX-API-DMAC7.html)
MX (1) MX2019000255A (cg-RX-API-DMAC7.html)
PE (1) PE20190321A1 (cg-RX-API-DMAC7.html)
PH (1) PH12019500024A1 (cg-RX-API-DMAC7.html)
SG (1) SG11201811223YA (cg-RX-API-DMAC7.html)
WO (1) WO2018015175A1 (cg-RX-API-DMAC7.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022071461A1 (ja) * 2020-10-02 2022-04-07 住友精化株式会社 粘性組成物
WO2022071463A1 (ja) * 2020-10-02 2022-04-07 住友精化株式会社 粘性組成物

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60318456T2 (de) * 2002-06-17 2008-12-24 Resolvyx Pharmaceuticals, Bedford ANALOGA VON OMEGA-3-PUFAs ABGELEITETEN LIPIDMEDIATOREN UND ANWENDUNGSVERFAHREN
WO2008145183A1 (en) * 2007-05-30 2008-12-04 Nestec S.A. Oil-in-water emulsion and its use for the delayed release of active elements
GB2465988A (en) * 2008-12-03 2010-06-09 Omegatri As Powder or tablet containing unsaturated fatty acid and water insoluble carbohydrate
JP6176894B2 (ja) * 2009-03-09 2017-08-09 プロノヴァ・バイオファーマ・ノルゲ・アーエス 脂肪酸油混合物及び界面活性剤を含む組成物、並びにその方法及び使用
CN102512664B (zh) * 2010-12-31 2015-04-01 舒泰神(北京)生物制药股份有限公司 一种神经生长因子组合物
SG11201403805WA (en) 2012-01-06 2014-08-28 Omthera Pharmaceuticals Inc Dpa-enriched compositions of omega-3 polyunsaturated fatty acids in free acid form

Similar Documents

Publication Publication Date Title
ES2385240B1 (es) Cápsulas de principios activos farmacéuticos y ácidos grasos poliinsaturados para el tratamiento de enfermedades de la próstata.
JP2018184458A5 (cg-RX-API-DMAC7.html)
NO20070175L (no) Farmasoytiske sammensetninger som inneholder polyumettede fettsyrer og minst et immunsupressivt virkemiddel eller et antineoplastisk virkemiddel
JP2016065086A5 (cg-RX-API-DMAC7.html)
JPS6410494B2 (cg-RX-API-DMAC7.html)
RU2017134002A (ru) Стабильные композиции тетрагидробиоптерина
DE04801160T1 (de) Pharmazeutische zusammensetzungen mit lercanidipin
WO2014170464A1 (en) Encapsulation of an oil containing unsaturated fatty acids
JP2019500416A (ja) デュタステリド及びプロピレングリコールモノラウレートを含有する医薬組成物及びその調製方法
IL273754B1 (en) Fortified oral taxane preparations and methods
JP2017505809A5 (cg-RX-API-DMAC7.html)
JP5795585B2 (ja) 固体粉末化合物からのフィルムコーティング組成物
JP6103111B1 (ja) 経口医薬組成物及び該組成物からなる粒子状製剤の製造方法
JP2024033011A (ja) 医薬組成物
JP2019520393A5 (cg-RX-API-DMAC7.html)
JP2019509344A5 (cg-RX-API-DMAC7.html)
EP3195860A1 (de) Verfahren zur herstellung eines apixaban-granulates
WO2015019237A1 (en) Pharmaceutical composition of vilazodone
RU2012116085A (ru) Наночастицы оксалиплатина и способ их получения
CN101141952B (zh) 新的软胶囊
JP2019534046A5 (cg-RX-API-DMAC7.html)
MY191983A (en) Pharmaceutical formulations comprising sodium palmitoyl-l-prolyl-l-prolyl-glycyl-l-tyrosinate and methods for preparing the same
WO2015016698A1 (es) Composición farmacéutica con agentes antiinflamatorios y proceso de producción
WO2018069805A3 (en) Method for preparation of liquid oral composition of l-thyroxin
JP5191121B2 (ja) 溶解性を改善したジフェンヒドラミン含有医薬組成物